Fertility Preservation Special Interest Group (FPSIG)
FPSIG’s Mission Statement
The Fertility Preservation Special Interest Group promotes knowledge among health care workers and the public on infertility induced by cancer therapy and other medical treatments through national and international collaboration among Reproductive Specialists, Oncologists, and Allied Health Workers to promote research, education and to develop new strategies of fertility preservation.2025-2026 Fertility Preservation Special Interest Group Leadership
- Chair: Dr. Julie Rios
- Chair Elect: Dr. May-Tal Sauerbrun-Cutler
- Vice Chair: Dr. Kutluk Oktay
- Immediate Past Chair: Dr. Leslie Appiah
- Past Chair: Dr. Gwendolyn Quinn
ASRM Membership
Benefits of Membership
Reach your potential as a reproductive health professional and join the community advancing reproductive medicine with your ASRM membership.
ASRM Membership Dues
All memberships come with online access to Fertility and Sterility, F&S Science, F&S Reviews, and F&S Reports.
Discounted Membership
Individuals joining or renewing membership in ASRM that reside in low or low-middle income countries (as defined by the World Bank) now receive a discount on ASRM membership!
Welcome New ASRM Members!
It is with great pleasure that the American Society for Reproductive Medicine (ASRM) acknowledges and thanks the following people for their new membership in the Society.
ASRM Affiliated Societies
ASRM Affiiliated Societies are made up of professionals who have special training and expertise in specific areas of reproductive medicine.
ASRM Professional Groups
ASRM Professional Groups allow members to network and collaborate with other professionals who have an interest in the field of reproductive medicine.
ASRM Special Interest Groups
ASRM Special Interest Groups provide programming and leadership to physicians and health professionals who have a special interest in a particular area of reproductive medicine.
Membership Directory
ASRM Members can find contact information for other members by visiting ASRM Connect, the new community hub for ASRM membership.
Have a Special Interest?
Interested in seeing what other ASRM Special Interest Groups are available?
Topic Resources
View more on the topic of fertility preservation
Fertility preservation and reproduction in patients facing gonadotoxic therapies or gonadectomy: an Ethics Committee opinion (2026)
Patients receiving gonadotoxic treatment should be informed of options for fertility preservation and future reproduction prior to such treatment. View the Committee Opinion
Fertility preservation in patients with medical indications: a committee opinion (2026)
Expert guidelines on fertility preservation options—oocyte, embryo, ovarian and testicular tissue cryopreservation and counseling before gonadotoxic treatment. View the Committee Opinion
Fertility and Sterility On Air - Live from the American Association of Gynecologic Laparoscopists 2025 Global Congress
Expert surgeons and REIs explore cutting-edge adenomyosis diagnosis and treatment to improve fertility outcomes, live from AAGL-ASRM. Listen to the Episode
Fertility and Sterility Publishes New Research Underscoring Importance of IVF, Fertility Preservation Access for Cancer Patients During Breast Cancer Awareness Month
New ASRM‑supported research highlights key IVF and fertility preservation access needs for cancer patients — particularly during Breast Cancer Awareness Month. View the Press Release
Fertility and Sterility On Air - Unplugged: October 2025
Circadian rhythms, bariatric surgery, IL‑22, and mTOR’s role in fertility—hear expert insights in ASRM’s latest Fertility & Sterility Unplugged episode. Listen to the Episode
Fertility and Sterility On Air - Roundtable: Egg Sharing
Experts debate the ethics of egg sharing and split cycles, exploring patient autonomy, informed consent, diversity, and equitable fertility care. Listen to the Episode
Oocyte cryopreservation
We code 89337 (cryopreservation of oocytes) for the entire oocyte preservation cycle, including monitoring visits. View the Answer
Reimplantation of cryopreserved ovarian tissue
What is the correct code for laparoscopic reimplantation of ovarian tissue? View the Answer
Planned oocyte cryopreservation to preserve future reproductive potential: an Ethics Committee opinion (2023)
Planned oocyte cryopreservation is an ethically permissible procedure that may help individuals avoid future infertility. View the Committee Opinion
Z Codes Vs. Procedure Codes For Fertility Preservation Counseling
I am trying to understand better when to use the procreative management code vs the fertility preservation counseling and procedure codes. View the Answer
Elective fertility preservation is ART
From an insurance standpoint, is fertility preservation is considered an assisted reproductive technology or would it be branched under other? View the Answer
Oocyte Preservation Consult
Our center performs oocyte preservation procedures for women looking to preserve their fertility. View the Answer
Fertility Preservation Consult
What code are we supposed to use for counseling regarding fertility preservation for an individual with cancer... View the Answer
Coding For Ovarian Tissue Cryopreservation
Now that ASRM has removed the "experimental" designation from ovarian tissue cryopreservation what CPT code should be used instead of 0058T? View the Answer
Cycle Monitoring Fertility Preservation
If the patient is undergoing ultrasound tracking visits for fertility preservation, what I ICD-10 code do you use for the monitoring? View the Answer
Fertility Preservation
A summary of codes for Fertility Preservation compiled by the ASRM Coding Committee. View the Coding Summary
Access to fertility services by transgender and nonbinary persons: an Ethics Committee opinion (2021)
The provision of fertility services to transgender individuals and the denial of access to fertility services is not justified. View the Committee Opinion
Reproductive and hormonal considerations in women at increased risk for hereditary gynecologic cancers: Society of Gynecologic Oncology and American Society for Reproductive Medicine Evidence-Based Review (2019)
Providers who care for women at risk for hereditary gynecologic cancers must consider the impact of these conditions. View the Joint Statement
